Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation - PubMed (original) (raw)
. 2007 Apr 19;26(18):2535-42.
doi: 10.1038/sj.onc.1210049. Epub 2006 Oct 16.
Affiliations
- PMID: 17043640
- DOI: 10.1038/sj.onc.1210049
Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation
P J Hurley et al. Oncogene. 2007.
Abstract
The vast majority of cancer cells have defective checkpoints that permit the cell cycle to progress in the presence of double-strand DNA breaks (DSBs) caused by ionizing radiation (IR) and radiomimetic drugs. ATR (ataxia telangiectasia-mutated and Rad3-related) has recently been shown to be activated by DSBs, although the consequences of this activity are largely unknown. In this report, we use advanced gene targeting methods to generate biallelic hypomorphic ATR mutations in human colorectal cancer cells and demonstrate that progression of the cancer cell cycle after IR treatment requires ATR. Cells with mutant ATR accumulated at a defined point at the beginning of the S phase after IR treatment and were unable to progress beyond that point, whereas cells at later stages of the S phase during the time of irradiation progressed and completed DNA replication. The prolonged arrest of ATR mutant cancer cells did not involve the ataxia telangiectasia mutated-dependent S-phase checkpoint, but rather closely resembled a previously characterized form of cell cycle arrest termed S-phase stasis. As ATR strongly contributed to clonogenic survival after IR treatment, these data suggest that blocking ATR activity might be a useful strategy for inducing S-phase stasis and promoting the radiosensitization of checkpoint-deficient cancer cells.
Similar articles
- ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining.
Wang H, Wang H, Powell SN, Iliakis G, Wang Y. Wang H, et al. Cancer Res. 2004 Oct 1;64(19):7139-43. doi: 10.1158/0008-5472.CAN-04-1289. Cancer Res. 2004. PMID: 15466211 - ATR (AT mutated Rad3 related) activity stabilizes Cdc6 and delays G2/M-phase entry during hydroxyurea-induced S-phase arrest of HeLa cells.
Liu L, Choi JH, Yim H, Choi JS, Park BD, Cho SJ, Lee SK. Liu L, et al. Int J Biochem Cell Biol. 2009 Jun;41(6):1410-20. doi: 10.1016/j.biocel.2008.12.014. Epub 2008 Dec 30. Int J Biochem Cell Biol. 2009. PMID: 19154794 - Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints.
Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL, Friend SH. Cliby WA, et al. EMBO J. 1998 Jan 2;17(1):159-69. doi: 10.1093/emboj/17.1.159. EMBO J. 1998. PMID: 9427750 Free PMC article. - Regulation of DNA replication by ATR: signaling in response to DNA intermediates.
Shechter D, Costanzo V, Gautier J. Shechter D, et al. DNA Repair (Amst). 2004 Aug-Sep;3(8-9):901-8. doi: 10.1016/j.dnarep.2004.03.020. DNA Repair (Amst). 2004. PMID: 15279775 Review. - Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer.
Deng S, Vlatkovic T, Li M, Zhan T, Veldwijk MR, Herskind C. Deng S, et al. Cancers (Basel). 2022 Oct 5;14(19):4874. doi: 10.3390/cancers14194874. Cancers (Basel). 2022. PMID: 36230796 Free PMC article. Review.
Cited by
- Metastasis-associated gene 1 (MTA1) enhances cisplatin resistance of malignant pleural mesothelioma by ATR-Chk1-mediated DNA repair.
Xu C, Hu Y, Chen B, Li D, Liang R, Shen M, Wu M, Tao M. Xu C, et al. Ann Transl Med. 2021 Apr;9(8):670. doi: 10.21037/atm-21-941. Ann Transl Med. 2021. PMID: 33987368 Free PMC article. - Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival.
Wilsker D, Chung JH, Pradilla I, Petermann E, Helleday T, Bunz F. Wilsker D, et al. Mol Cancer Ther. 2012 Jan;11(1):98-107. doi: 10.1158/1535-7163.MCT-11-0675. Epub 2011 Nov 14. Mol Cancer Ther. 2012. PMID: 22084169 Free PMC article. - Cross-species Functionome analysis identifies proteins associated with DNA repair, translation and aerobic respiration as conserved modulators of UV-toxicity.
Rooney JP, Patil A, Joseph F, Endres L, Begley U, Zappala MR, Cunningham RP, Begley TJ. Rooney JP, et al. Genomics. 2011 Mar;97(3):133-47. doi: 10.1016/j.ygeno.2010.12.005. Epub 2010 Dec 30. Genomics. 2011. PMID: 21195161 Free PMC article. - Targeting ATR in Cancer Medicine.
Salguero C, Valladolid C, Robinson HMR, Smith GCM, Yap TA. Salguero C, et al. Cancer Treat Res. 2023;186:239-283. doi: 10.1007/978-3-031-30065-3_14. Cancer Treat Res. 2023. PMID: 37978140 - Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.
Wilsker D, Petermann E, Helleday T, Bunz F. Wilsker D, et al. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20752-7. doi: 10.1073/pnas.0806917106. Epub 2008 Dec 17. Proc Natl Acad Sci U S A. 2008. PMID: 19091954 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous